Posted
"The report of this successful Phase three trial (by Eisai Co Ltd and Biogen Inc) in early Alzheimer's disease will change the landscape of Alzheimer's treatment in this country and worldwide,” said Dr. Lawrence Honig, professor of neurology at Columbia University Medical Center.
01:42
01:19
01:57
02:11
01:13
03:02
01:29
02:29
02:41
01:53
01:05
02:20
01:14
01:35
01:49
02:43
01:33
01:21
01:09
00:26
01:54
01:43
01:30
02:44
00:45
01:56
00:59
00:52
00:45
01:50
01:21
02:19
02:22
00:36
00:58
01:54
01:09
02:46
00:34
02:12
01:17
02:16
01:13
01:19
00:37
02:11
01:51
02:06
01:12
01:25
01:14
02:32
01:15
03:08
00:57
01:19
01:25
01:22
00:56
00:27
01:06
00:51
01:03
00:34
00:38
00:33
01:05
01:59
01:11
00:37
01:12
01:22
01:29
01:23
00:59
01:22